Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain
Clinical trial NCT02143713 · COMPLETED
Trial details
- NCT number
- NCT02143713
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-27
- Primary completion
- 2016-06-22
- Enrollment
- 496
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.